Sign inCompoundsWolverine Stack
Layer A — first-party, cited authorityLayer B — disclaimed UGC & research toolsNo first-party human-dosing guidance, ever.
00–01 · 40 · 15

Overview

The single most cited surface

Wolverine Stack

Research use only

peptideWolverineWolverine StackWolverine Blend
Wound healingTendon ligament repair
studies indexed
2026-07-16T22:24:27.560076+00:00 last verified
Best verified price / mg
$2.50/mg
across 16 tracked vendors · United States
Median $/mg
$9.05
Studies indexed
Evidence maturity
Not yet rated
Community sentiment
Not yet rated

Researched goals

CitedgoalTags

Areas of active research — not promised effects

Each tag links to other compounds with research into that goal. Research use only: these are areas of study, not human-use claims.

Similar peptides

M11 · M23

Related by research scope · open each to compare

No data availableNo related compounds are linked for this entry yet.

Status at a glance

CitedM0
United States: Status unavailable

Regulatory detail for this region is not available in the current seed.

Buyer-confidence index

M40
No data availableSourcing-confidence signal is still collecting for this compound — not enough cited market data to publish a number yet.

Sourcing sub-inputs

M40
No data availableNot enough cited market data to chart sourcing sub-inputs yet.

Trust & provenance

CitedM15
PC
Reviewed by the PeptideCompass editorial team
Independent · no paid placement · last verified 2026-07-16T22:24:27.560076+00:00
Changelog & edit history Methodology Report an error
01 · 02 · 25 · 09 · 37 · 38

Identity & chemistry

Identity & registry

CitedM1
Primary name
Wolverine Stack

Chemical & physical

CitedM2

Structure & sequence

CitedM25
Multi-component blend · 2 constituentsNo single molecule — see each constituent’s structure.

Sequence not available in current seed.

SDS & lab handling

CitedM37
  • GHS hazard class on file
  • PPE & spill response
  • Disposal guidance
  • Not-for-human-consumption posture
NEW

Blend components

Wolverine Stack is a blend — its science is inherited from each cited component, not measured as a single molecule.

BPC-157

Animal / in-vitroCitedBlend

Synthetic 15-amino-acid gastric pentadecapeptide studied in animal models for tissue repair, angiogenesis, and GI protection.

Synthetic pentadecapeptide; gastric mucosal-derived sequence

BPC-157 has been shown in rodent and cell-culture studies to upregulate vascular endothelial growth factor receptor 2 (VEGFR2) and activate downstream Akt–eNOS signaling, promoting endothelial nitric oxide production and new vessel formation. The peptide also engages the focal adhesion kinase (FAK)–paxillin pathway, facilitating endothelial cell migration during angiogenesis. Additional preclinical data indicate modulation of nitric oxide synthesis more broadly, with context-dependent protective effects against cytotoxic NO excess while preserving physiological NO-mediated functions. These converging angiogenic and cytoprotective pathways are proposed to underlie observations of accelerated wound closure, tendon reattachment, and gastrointestinal mucosal recovery in animal injury models.

Molar mass
1419.5 g/mol
View full datasheet

TB-500

Animal / in-vitroCitedBlend

Synthetic 9-amino-acid fragment (Ac-LKKTETQ) of thymosin beta-4 studied in animal models for tissue repair, cell migration, and angiogenesis.

Synthetic actin-sequestering peptide fragment; thymosin beta-4 active-domain fragment (residues 17–23, acetylated)

TB-500 binds monomeric G-actin through the same LKKT(X)E motif present in the full thymosin beta-4 protein, sequestering free actin monomers and preventing their incorporation into filamentous F-actin networks; this shifts the intracellular actin equilibrium in a manner that facilitates lamellipodia formation and directed cell migration. Concurrently, the peptide activates integrin-linked kinase (ILK) signaling, promoting downstream phosphorylation events that stimulate keratinocyte and endothelial cell motility. In rodent wound and ischemia models, these effects are accompanied by upregulation of vascular endothelial growth factor (VEGF) and accelerated capillary sprouting, suggesting a secondary pro-angiogenic axis. NF-kB pathway modulation has also been reported in preclinical inflammation models, though the mechanistic hierarchy relative to actin sequestration remains unresolved.

Molar mass
889.0 g/mol
View full datasheet
03 · 04 · 4A · 30 · 05

Evidence & efficacy

Evidence at a glance

M4

How much research exists, and of what maturity — never a verdict on whether it works.

No data availableNo indexed literature is on file for this compound yet — evidence maturity is not characterized.

Does it actually work? — proven vs anecdotal

CitedM4A
Strong humanLimited humanAnimal / in-vitroMechanisticAnecdotal only

Pharmacology

CitedM3

Evidence & literature

CitedM4
indexed articles
0registered human trials
last scanned

Reading the evidence

  • Evidence quality and gaps vary by application — see the cited grades above.
  • Indexed-article counts span all evidence tiers, not only completed human trials.
  • No first-party human-dosing, efficacy, or benefit claims are made here.

Human-trial pipeline

CitedM30

No registered human trials found for this compound.

Status
No registered trials found
NEW

Routes of administration

How Wolverine Stack has been studied — pharmacology, not a protocol. RUO.

Dominant research route & oral stability

CitedRoutes

Routes

No data availableNo route-of-administration research is on file for this compound yet.
4B · 10

Dosage reference & research tools

Dosage reference spectrum

UGC · disclaimedM4B
No data availableNo structured dosage-reference rows are on file yet.

Animal & human figures are kept visibly separate so studied animal doses are never misread as human guidance.

Reconstitution calculator

UGC · disclaimedM10
mg
mL
Concentration
5.00 mg/mL
For a 250 mcg reference unitdraw 0.050 mL= 5.0 units (U-100)
Reconstituted stability22 of 28 days left

Research unit-conversion only · not for human use

07 · 08 · 24 · 34 · 35 · 33

Vendors & price intelligence

United States

Vendor & price comparison

CitedM7 · M8

Sorted A–Z by vendor — never by price

Median $/mg
$9.05
Range $2.50$44.00
Vendors tracked
16
In stock
16
With COA
16
Weekly median · 5w

As of 2026-08-06· research-catalog listings, dated & cited — no ranking, no commission earned, never sorted by price. Research use only.

VendorFormat · sizePricePrice / mgCOAStockSource
AMAmerican Peptides
20 mgVial$195$9.752026-07-26
AMAminoVault
20 mgVial$231$11.552026-08-04
BIBioLongevity Labs
10 mgVial$120$12.002026-08-02
BIBiotech Peptides
10 mgVial$115$11.502026-08-04
CECenexa Labs
10 mg · 20 mgVial$6.75–$9.002026-08-06
COCoastal Peptides
10 mgVial$80.00$8.002026-08-02
COCosmic Peptides
5 mg · 10 mgVial$9.00–$11.802026-08-01
GEGenX Peptides
10 mgVial$80.00$8.002026-08-05
HAHappy Peptides
10 mgVial$98.00$9.802026-08-02
HOHonest Peptide
10 mgVial$91.00$9.102026-08-04
ONOnyx Biolabs
10 mg · 20 mgVial$5.00–$7.002026-08-06
OROrbitrex Peptides
20 mgVial$89.99$4.502026-08-03
PEPeptide Partners
20 mgVial$880$44.002026-08-05
PRPrime Peptides
20 mgVial$50.00$2.502026-08-05
SKSkye Peptides
5 mg · 10 mgVial$10.90–$12.802026-08-02
UMUmbrella Labs
Topical$1752026-07-24
VEVerified Peptides
20 mgVial$107$5.352026-07-31
WOWolverine Peptides
Topical$1302026-08-06

Crawled vendor listings, sorted A–Z by vendor — never by price.

Price-per-mg history

CitedM8
$9.38$8.55$7.724w3w2w1wnow

Weekly median $/mg from the live vendor crawl.

Price distribution

M8

Researched storefront prices, bucketed

No data availablePrice distribution derives from verified vendor pricing, which is not yet collected for this compound.

Cross-region & vial-size economics

M8

Cross-region pricing

United States (researched)
Collecting
Canada
Collecting
United Kingdom
Collecting
European Union
Collecting

Only the US market has been researched so far — no FX conversion is applied.

Vial-size economics

No data availableNo vial-size data is on file yet.

Bigger vials generally lower $/mg but raise reconstitution-waste risk.

Cost & value analytics

M24
No data availableCost-per-research, reliability and bulk analytics derive from verified vendor pricing, which is not yet collected for this compound.

Vendor reliability

M34
No data availableOn-time / reship reliability metrics require the live crawl's fulfillment history, which is not collected yet.

Bulk / B2B procurement

M35
No data availableWholesale / vendor-direct pricing tiers are not researched yet.

Licensed clinics & 503A

CitedM33

Segregated from gray-market research vendors · shown only where lawful.

Opens as US reclassification formalizes
19 · 36 · 20 · 18 · 32

Quality, verification & alerts

Quality, testing & COA verification

M19 · M36

What each test proves — general guidance, plus this compound's researched purity data

HPLC
Purity %
Mass spec (MS)
Identity — the only proof it is the right molecule
Potency / quantitation
Catches underdosing
Endotoxin (LAL)
EU/mg
Heavy metals
Contamination
Residual solvents
Process residue
Sterility / bioburden
Microbial
Lot / batch traceability
Provenance
Verify your vial's COA — paste a Janoshik task # to check authenticity & recency (< 6 mo).

Independent labs cited for this compound

No independent labs cited for this compound yet.
Reference MS/HPLC data not on file yet.

Counterfeit & recall alerts

M20
No data availableNo enforcement or recall events are on file for this compound.

Buyer red-flag checklist

  • No COA / in-house only
  • Price < ~$3/mg
  • Crypto-only payment
  • No contact info
  • No reship policy
  • Old or photoshopped COA (> 6 mo)

Manufacturing, grade & supply chain

CitedM18

GMP vs research-grade: the chemistry (SPPS + HPLC + MS) is identical — the difference is the quality system.

Shipping, customs & landed cost

CitedM32
  • An RUO label is not an import exemption — CBP judges actual intended use.
  • Lyophilized powder is ambient-stable in transit; temperature control needed for > 7-day transit.
  • US-warehouse vendors dodge import scrutiny — they cost more but ship more reliably.
06 · 6A · 31 · 44

Regulatory & developments

United States

Regulatory status & timeline

CitedM6
No data availableNo regulatory timeline is on file yet.

Latest news & developments

M6A

Every item dated & sourced

No data availableNo dated news items are on file yet.

WADA anti-doping status

WADA
No data availableNo WADA status is on file for this compound.

Patent & IP landscape

CitedM31

No granted patents identified in current seed. Composition-of-matter coverage is limited given the peptide's synthetic origin.

Use-context & responsibility

CitedM44
  • IACUC / IRB research context
  • RUO buyer responsibilities & documentation
  • Veterinary / alternative-use where lawful
  • Jurisdiction-aware "who may lawfully obtain"
12 · 17 · 22 · 39 · 13 · 11 · 23

Community, sentiment & answers

FAQ

CitedM13

Community sentiment

UGC · disclaimedM22
Collecting community signalListening across Reddit, Bluesky, YouTube and X. This fills in as public discussion accrues — we don't show a number until there's enough to be honest about.

Community Sentiment — Layer B. This reflects the tone of public discussion across Reddit, Bluesky, YouTube and X over the last 90 days. It measures how a compound is discussed and received, not whether it is safe, effective, or appropriate for any use. It is not medical, dosing, or purchasing advice and is not an endorsement. Posts are aggregated and de-identified; individual comments, claims, and dosing discussion are never shown. Research use only.

Community themes & reported concerns

UGC · disclaimedM12 · M39

What people discuss

No data availableNo community-discussion themes are on file yet.

Reported concerns — discussion, not established effects

No data availableNo reported concerns are on file yet.
41 · 21 · 42 · 28 · 27 · 26 · 29 · 43 · 14 · 16

Tools, market & meta

Research & market activity

M21

Relative research / market volume — populated once the activity stream is wired

No data availableA per-compound research and market activity stream is not collected yet.

Ask this datasheet

CitedM41
Grounded only in this compound's cited data · refuses dosing advice

Watch & listing momentum

M21
No data availableWatch and listing momentum derive from the vendor crawl, not yet wired for this compound.

Lifecycle & market history

M42
No data availableMarket lifecycle and price history are not collected for this compound yet.

Data confidence & contribute

CitedM28
VerifiedVendor-statedCommunityStale

Glossary & reading mode

CitedM27

Inline tooltips for lyophilized, RUO, EU/mg, SPPS, 503A and more.

Toggle plain-language ↔ scientific in the header.

Guides & explainers

CitedM26
  • How to read a COA
  • Free base vs acetate
  • Understanding evidence grades

Market intelligence

M43
No data availableCategory sizing and demand intelligence are not collected for this compound yet.

Citable summary (GEO)

DerivedM14

Research use only.

Emitted as JSON-LD: ChemicalSubstance · BreadcrumbList · FAQPage.

Save, track & alerts

CitedM16
  • Price-drop & back-in-stock alerts
  • Regulatory-change email digest
  • Print / share this datasheet

Export, citation & data

CitedM29
reviewed by the PeptideCompass editorial team